Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Inamed Performance Enhanced By Tech Assessment: Shares Up 38% In May

This article was originally published in The Gray Sheet

Executive Summary

Positive safety results from an NIH-sponsored, retrospective study of silicon gel breast implants triggered a $14.25 leap in Inamed shares for the month of May

You may also be interested in...



Silicone Breast Implant Data Requirements Questioned By Patient Groups

FDA's General & Plastic Surgery Devices Panel will likely consider gel migration and "silent rupture" of silicone breast implants when reviewing Inamed's premarket application

Silicone Breast Implant Data Requirements Questioned By Patient Groups

FDA's General & Plastic Surgery Devices Panel will likely consider gel migration and "silent rupture" of silicone breast implants when reviewing Inamed's premarket application

NCI Silicone Breast Implant Study Will Assess Connective Tissue Disease

Follow-up analyses of a 13,500-patient silicone breast implant study will evaluate the relationship of the devices to connective tissue diseases (CTD), according to a 1report submitted to Congress by the National Institutes of Health April 24

UsernamePublicRestriction

Register

OM005385

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel